Senhwa Biosciences announces positive data from phase 1/expansion trial of Silmitasertib for basal cell carcinoma treatment: Taipei, Taiwan Thursday, April 3, 2025, 15:00 Hrs [IST ...

The agreement supports the intended evaluation of Immuneering's lead product candidate, IMM-1-104, in combination with Libtayo in patients with unresectable or metastatic RAS-mutant non-small cell ...

in combination with Libtayo in patients with unresectable or metastatic RAS-mutant non-small cell lung cancer (NSCLC). Positive Data Update from Three Pancreatic Cancer Arms of Ongoing Phase 2a ...

The Polokwane-based winger Oswin Appollis said they have been putting the hard yard and he feels through the hard work they will secure a positive result. “You know, it’s going to be a tough game – ...

4 During 2024, investments of $10.1 billion formerly included in the Real-rate products were transferred to other investment strategies within Fixed income ($9.2 billion) and Credit ($0.9 billion).

Rich Wilson, President and Chief Executive Officer, commented, "We are pleased with the continued trend of same-store sales increases as September marks the eighth consecutive month of positive ...

The study also found that adding CyPath® Lung to the standard of care for private-payer patients with a positive lung cancer screening result could have saved even more, an average of $6,460 per ...

John Newlands, Develop North chair, said: “Although sentiment has dipped following the Budget, and businesses clearly face additional costs, we continue to have a positive outlook for 2025. “This view ...